[
  {
    "ts": null,
    "headline": "Biotech Is Booming, and This Undervalued REIT Stands to Gain",
    "summary": "While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate industry that's breeding breakout growth: life sciences.  Global biotech spending is projected to triple from roughly $1.7 trillion in 2025 to more than $5 trillion by 2034.  All that R&D cash needs purpose‑built laboratory space.",
    "url": "https://finnhub.io/api/news?id=69f44bc81dd3d18f79ecbbcdcc74636a38f005712eb2495255fea43e8607b837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753479360,
      "headline": "Biotech Is Booming, and This Undervalued REIT Stands to Gain",
      "id": 136095093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate industry that's breeding breakout growth: life sciences.  Global biotech spending is projected to triple from roughly $1.7 trillion in 2025 to more than $5 trillion by 2034.  All that R&D cash needs purpose‑built laboratory space.",
      "url": "https://finnhub.io/api/news?id=69f44bc81dd3d18f79ecbbcdcc74636a38f005712eb2495255fea43e8607b837"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC",
    "summary": "Earnings preview of key companies reporting in the coming week and what to look out for.",
    "url": "https://finnhub.io/api/news?id=675d305c685a59b79d1453c7382d6ed52d84d8edd73e7259243df69108a0ab3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753454192,
      "headline": "Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC",
      "id": 136088416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Earnings preview of key companies reporting in the coming week and what to look out for.",
      "url": "https://finnhub.io/api/news?id=675d305c685a59b79d1453c7382d6ed52d84d8edd73e7259243df69108a0ab3c"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?",
    "summary": "Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=d1992b06ff04270a463fcaa95a53c590b6cc1493eb03a8c1a19ce7a0be63b597",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753452008,
      "headline": "Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?",
      "id": 136089198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=d1992b06ff04270a463fcaa95a53c590b6cc1493eb03a8c1a19ce7a0be63b597"
    }
  },
  {
    "ts": null,
    "headline": "REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?",
    "summary": "Strong Dupixent profits and rising Eylea HD demand may help Regeneron offset pressure in its Q2 earnings report.",
    "url": "https://finnhub.io/api/news?id=7a05da8362952a19605cde8ebf11eb785588f086f7846d595caabeb7ca375ffd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753451880,
      "headline": "REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?",
      "id": 136088720,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Strong Dupixent profits and rising Eylea HD demand may help Regeneron offset pressure in its Q2 earnings report.",
      "url": "https://finnhub.io/api/news?id=7a05da8362952a19605cde8ebf11eb785588f086f7846d595caabeb7ca375ffd"
    }
  },
  {
    "ts": null,
    "headline": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1",
    "summary": "Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that ...",
    "url": "https://finnhub.io/api/news?id=066b93083f8d80cf5d6605d3e4231a8dc1a97a4308b4622e35a19d07b2ea75fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753447500,
      "headline": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1",
      "id": 136089200,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that ...",
      "url": "https://finnhub.io/api/news?id=066b93083f8d80cf5d6605d3e4231a8dc1a97a4308b4622e35a19d07b2ea75fb"
    }
  }
]